Viewing Study NCT04923425



Ignite Creation Date: 2024-05-06 @ 4:14 PM
Last Modification Date: 2024-10-26 @ 2:06 PM
Study NCT ID: NCT04923425
Status: COMPLETED
Last Update Posted: 2021-06-16
First Post: 2021-06-06

Brief Title: Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy
Sponsor: Cairo University
Organization: Cairo University

Study Overview

Official Title: Gustatory Modulators Among a Sample of Depressed Egyptian Adults Under Anti-depressants Therapy A Retrospective Cohort Study
Status: COMPLETED
Status Verified Date: 2021-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Identify possible modulators for developing gustatory dysfunction among a sample of depressed Egyptian adults age from 20 to 50 years old under anti-depressants therapy for at least 3 months using a questionnaire appendix with a binary measuring unit yesno
Detailed Description: PECO

P Population depressed Egyptian adults under anti-depressants therapy
E1 Exposure 1 commonly prescribed tricyclic antidepressants Imipramine Amitriptyline Clomipramine HCL
E2 Exposure 2 commonly prescribed Selective Serotonin Re-uptake inhibitors antidepressants Fluoxetine Fluvoxamine Sertraline Citalopram Paroxetine
C control non exposure non-pharmacological treatment psychotherapy
O Outcome Identify possible gustatory dysfunction modulators among these patients using a questionnaire appendix with a binary measuring unit yesno

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None